Mengchu Wu – CEO, Health Genetech, Taiwan
Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer…
Address: 6F, No 216-5, Sec. 2, Suiyuan Road, Taichung,Taiwan
Tel: +886 4 2247 3356
For over 15 years, with headquarter in central Taiwan and a branch office in Taipei, and as the pioneer of specialty pharmaceutical distribution locally, Giddi Pharma Co., Ltd. continues to provide excellent services to its global business partners, the local medical community, as well as patients’ advocacy and support groups.
Giddi’s expertise begins with comprehensive & extensive knowledge in various business channels and all distribution models. Its unique one-stop solution, turnkey service capacity has resulted in quick market entry with great efficiency plus cost-saving advantages. From individual named patient import to full scale commercial launch; from product registration, to insurance reimbursement and formulary listing; from international cold chain logistic to pharmacovigilance, Giddi offers comprehensive coverage in each and every aspect of product commercialization.
Giddi’s achievements include several ‘Distributor Excellent Performance Awards’ from Genzyme, 5 times ‘Special Contribution for Supply, Manufacture, Research & Development of Rare Disease Medications’ from Department of Health and Presidential ‘Golden Merchant Award’.
Synergism of innovative leadership with decades of experience from core management team has repeatedly enabled Giddi to formulate adaptive strategies, overcome all challenges and accomplish ultimate goals set by our principals. Each of its 64 employees is also 100% committed to the caring, professional, integrity motto with passion and responsibility.
Giddi’s achievements and successful track records have earned solid reputation and business from global companies like Genzyme, BioMarin, Ipsen and others. With 3 sales teams each dedicated to specific sector for in depth education and relationship cultivation, Giddi is able to maintain double digits growth year after year and becomes the industry leader.
Superior functional and technical expertise coupled with extensive industry knowledge makes Giddi Pharma the ideal choice for your local business partner in Taiwan!
Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer…
Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus Antrodia Camphorata. The company’s drug, Hocena®, has already received several…
Barry Lam, founder and chairman of Quanta Computer, shares the story of how he built the company into one of the world’s leading electronics and IT manufacturers. Lam then sheds…
With the USA and China locked in a trade war, China’s near neighbour Taiwan – with its strong scientific and technology base, political security and economic reliability – may stand…
Professor Shih-Hua Lin, president of Taiwan’s National Defense Medical Center, shares an overview of the academic and research environment of the institute as well as its role in cultivating the…
Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique role in supporting Foxconn’s transition into healthcare. Li…
William Foreman, president of AmCham Taipei, describes the attractiveness and challenges of Taiwan’s business landscape and the implications of US-China relations on the island. Foreman goes on to highlight the…
Leo Liu, president of GeneReach Biotechnology Corp, shares the story of the diagnostics startup and explains his strategy to transition the company from a leading animal health point-of-care device manufacturer…
Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness…
Tony Chung, CEO of Instant NanoBiosensors explains the potential of their fibre-optic biosensor technology – FOPPR, and the commercialization strategy for their light-sensing biomarker analyzer INB-D200. He also highlights Taiwan’s…
Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
See our Cookie Privacy Policy Here
